Why pinkwashing became a household word

Think Before You Pink 2012 Retrospective.

It’s time to #ThinkBeforeYouPink, and stop breast cancer before it starts!

More info and videos
  • Think Before You Pink, a project of Breast Cancer Action, launched in 2002 in response to the growing concern about the overwhelming number of pink ribbon products and promotions on the market.
    The campaign calls for more transparency and accountability by companies that take part in breast cancer fundraising, and encourages consumers to ask critical questions about pink ribbon promotions.
  • Video uploaded on 29 November 2013 by BCaction channel.
  • More BPA and EDCs chemicals videos on our YT channel.

PinkWashing Infographic

Is breast cancer prettier in pink?

Based on the book Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy.

Infographic from the documentary “Pink Ribbons, Inc.” directed by Léa Pool that shows how the devastating reality of breast cancer, which marketing experts have labeled a “dream cause,” has been hijacked by a shiny story of success. Based on the book Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy by Samantha King.

Novel theoretical approach to reduce antibiotic resistance

Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance

antibiotic-resistance image
Moffitt researchers have developed a novel mathematical method inspired by Darwinian evolution to use current antibiotics to eliminate or reduce the development of antibiotic-resistant bacteria.
Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteria via NIAID.

2015 Study Abstract

The increasing rate of antibiotic resistance and slowing discovery of novel antibiotic treatments presents a growing threat to public health. Here, we consider a simple model of evolution in asexually reproducing populations which considers adaptation as a biased random walk on a fitness landscape. This model associates the global properties of the fitness landscape with the algebraic properties of a Markov chain transition matrix and allows us to derive general results on the non-commutativity and irreversibility of natural selection as well as antibiotic cycling strategies. Using this formalism, we analyze 15 empirical fitness landscapes of E. coli under selection by different β-lactam antibiotics and demonstrate that the emergence of resistance to a given antibiotic can be either hindered or promoted by different sequences of drug application. Specifically, we demonstrate that the majority, approximately 70%, of sequential drug treatments with 2–4 drugs promote resistance to the final antibiotic. Further, we derive optimal drug application sequences with which we can probabilistically ‘steer’ the population through genotype space to avoid the emergence of resistance. This suggests a new strategy in the war against antibiotic–resistant organisms: drug sequencing to shepherd evolution through genotype space to states from which resistance cannot emerge and by which to maximize the chance of successful therapy.

Sources and more information
  • Moffitt Cancer Center Researchers Develop Novel Theoretical Approach to Reduce Antibiotic Resistance, moffitt, October 07, 2015.
  • Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance, PLOS one, DOI: 10.1371/journal.pcbi.1004493, September 11, 2015.

Pink Ribbon Culture Stereotyping and Breast Cancer Trivialization

Gayle Sulik “Pink Ribbon BLues”, Siena College, 2010

Dr. Gayle Sulik, author of Pink Ribbon Blues: How Breast Cancer Culture Undermines Women’s Health, spoke at Siena College on October 26, 2010.

More information
  • Medical sociologist Gayle A. Sulik’s book shows how advocacy, publicity, and mass marketing created a culture that transformed breast cancer from an important woman’s health problem in need of complicated social and medical solutions, to a popular item for public consumption.
  • Watch more pink washing videos on YouTube.

Booby Traps…

It’s cancer. Be public about it

breast-cancer-awareness cartoon
There must be better ways to raise awareness of breast cancer…

Ugh. here we go again. Another round of “Ssh don’t tell the boys, tee-hee” emails going around Facebook with ridiculous ideas about what to put on your status update under the premise of raising awareness of breast cancer. There’s so much wrong with this I actually get paralysed with rage when I think about it too much. ”

Continue reading Booby Traps, The House of J-Ro, 2011/11/16.

The effects in the human of DiEthylStilbestrol (DES) use during pregnancy

US National Library of Medicine National Institutes of Health, 1987

Diethylstilbestrol advert image
DiEthylStilbestrol usage review buttress the need for adequate and rigorous research into the use of drugs in pregnancy and ensure that they do more good than harm before being introduced for consumption.

1987 Study Abstract

Intrauterine diethylstilbestrol (DES) exposure is associated with an increased risk for the development of clear cell adenocarcinoma (CCA) of the vagina and cervix.

The age of the patients at diagnosis has varied from 7-35 years with the highest frequency from 14-22 years. The risk among the exposed, however, is small and is of the order of 1 per 1,000.

Almost all of the cases occur in postmenarchal females. Other factors that may increase the risk are maternal history of prior miscarriage, exposure to DES in early gestation, a fall season of birth and prematurity.

The occurrence of CCA has paralleled the sales of DES for pregnancy support in the U.S. Both vaginal adenosis (benign glands in the vagina) and CCA are more frequent among those whose mothers began DES in early pregnancy.

An increased risk of squamous cell neoplasia has been hypothesized but not proven. The changes that occur in the female genital tract of the DES exposed appear to result from alterations in the development of the mullerian ducts.

Currently there is not definitive evidence for an elevated risk of cancer among DES mothers or DES sons but studies have suggested a possible increase of breast cancer in the former group and testicular cancer in the latter group; a valid association has not been established in either.

Sources and more information
  • The effects in the human of diethylstilbestrol (DES) use during pregnancy, Princess Takamatsu Symposia 1987;18:67-75., NCBI PMID: 3506546.
More DES DiEthylStilbestrol Resources

Why Doctors are ReThinking Breast-Cancer Treatment

Too much chemo. Too much radiation. And way too many mastectomies

Too much chemo, too much radiation, and too many mastectomies. Why doctors are rethinking breast cancer treatment
Too much chemo, too much radiation, and too many mastectomies… why doctors are rethinking breast cancer treatment. Image via @TIMEHealth

What if I decide to just do nothing?

“It was kind of a taunt, Desiree Basila admits. Not the sort of thing that usually comes out of the mouth of a woman who’s just been diagnosed with breast cancer. For 20 minutes she’d been grilling her breast surgeon. “Just one more question,” she kept saying, and her surgeon appeared to her to be growing weary. She was trying to figure out what to do about her ductal carcinoma in situ (DCIS), also known as Stage 0 breast cancer, and she was already on her second opinion. The first surgeon had slapped a photograph of her right breast onto a viewer, pointed to a spot about 5 cm long and 2.5 cm wide and told her there was a slot open the following week for a mastectomy. “…

… continue reading Why Doctors Are Rethinking Breast-Cancer Treatment,
time, Oct. 1, 2015.
Watch the video: Low Risk DCIS Breast-Cancer Treatment New Approach.

Interview de Rachel Campergue ; décryptage de la campagne Octobre Rose

Dépistage cancer du sein : pour une réelle liberté de choix

Entretien du 20 octobre 2014 sur IDFM 98 Radio Enghien.
Vidéo publiée le 2 Nov 2014 par Joelle Verain.

Plus d’information

Epidemiologic aspects and factors related to survival in DES-associated cases of CCAC cancer

American Journal of Obstetrics and Gynecology, 1979

CCAC painting
DiEthylStilbestrol usage review buttress the need for adequate and rigorous research into the use of drugs in pregnancy and ensure that they do more good than harm before being introduced for consumption.

1979 Study Abstract

Three hundred and eighty-four cases of clear cell adenocarcinoma of the vagina and cervix accessioned in the Registry as of December 31, 1978, have been analyzed.

The annual incidence of these tumors has been found to correspond closely to the estimated usage of diethylstilbestrol (DES) for pregnancy support in the United States. The annual incidence of the DES-associated cases appears to have dropped in the United States in the past 2 years in comparison to 1973 to 1975.

The risk of tumor development appears to be higher in young women exposed to DES early in intrauterine life than in those exposed later. The carcinomas are rare before the age of 14 years and an irregular peak in the age-incidence curve appears between 17 and 21 years followed by a decline.

The 5-year survival rate is better for women over the age of 19 years than for younger patients, and a higher frequency oral contraceptive usage did not appear to influence the behavior of the tumor and the improved survival in those using this medication appears to be related to greater medical surveillance.

Sources and more information
  • Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix, American Journal of Obstetrics and Gynecology 1979 Dec 1;135(7):876-86, NCBI PMID: 507130.
More DES DiEthylStilbestrol Resources

Breast cancer: most men are not aware of their own risks

Breast cancer: are men the forgotten victims?

breast-cancer-lump-men image
It is estimated that 2,360 new cases of breast cancer will be diagnosed in men in the US this year, and around 430 men will die from the disease. A 2010 study found that 80% of men surveyed were not aware that men could even develop breast cancer, and the majority could not identify any symptoms of male breast cancer other than a lump in the breast.

2010 Study abstract

This article reports on the findings of a qualitative study that explored the awareness and knowledge of male breast cancer among English-speaking men. The primary goal was to elicit information to guide both clinical practice and the development of gender-specific educational interventions.

Interviews with 28 adult men, all of whom had no history of breast cancer themselves but had at least one maternal blood relative with the disease, were conducted and analyzed, using qualitative methods, to describe participants’ awareness of male breast cancer, their knowledge of the disease, and how they thought awareness of male breast cancer could be increased in health care providers and the lay public.

Nearly 80% of participants weren’t aware that men can get breast cancer; and although all were at higher risk given their positive family history, all reported that their providers had never discussed the disease with them. A majority couldn’t identify any symptoms other than a lump in the breast. About 43% voiced concerns that a diagnosis of breast cancer would cause them to question their masculinity. Participants also suggested ways that men, as well as providers and the lay public, could be better made aware of and educated about their risk for this disease.

This study provides much-needed insight into men’s awareness and knowledge of male breast cancer. While further research with larger samples is needed, these findings offer a starting point for the development of evidence-based, gender-specific, health promotion and disease prevention interventions for men.

Sources and more information